Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide NIH notice appears, explaining the agency’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error. The expected study details and related documents are removed, blocking access to the trial record.SummaryDifference17%

- Check52 days agoChange DetectedRevision label updated to v3.7.0, replacing the previous v3.6.6. This indicates a minor page release/update that does not alter the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.